468 related articles for article (PubMed ID: 1905309)
1. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
[TBL] [Abstract][Full Text] [Related]
2. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
3. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.
Smitz J; Erard P; Camus M; Devroey P; Tournaye H; Wisanto A; Van Steirteghem AC
Hum Reprod; 1992 Oct; 7(9):1225-9. PubMed ID: 1479002
[TBL] [Abstract][Full Text] [Related]
4. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
[TBL] [Abstract][Full Text] [Related]
5. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
[TBL] [Abstract][Full Text] [Related]
6. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.
Beckers NG; Laven JS; Eijkemans MJ; Fauser BC
Hum Reprod; 2000 Jan; 15(1):43-9. PubMed ID: 10611186
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
[TBL] [Abstract][Full Text] [Related]
8. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
[TBL] [Abstract][Full Text] [Related]
10. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
11. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
Tavaniotou A; Albano C; Smitz J; Devroey P
Hum Reprod; 2001 Apr; 16(4):663-7. PubMed ID: 11278214
[TBL] [Abstract][Full Text] [Related]
12. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
Claman P; Domingo M; Leader A
Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
[TBL] [Abstract][Full Text] [Related]
13. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
14. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
15. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
[TBL] [Abstract][Full Text] [Related]
16. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
Tavaniotou A; Albano C; Smitz J; Devroey P
Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
[TBL] [Abstract][Full Text] [Related]
17. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
Mochtar MH; Hogerzeil HV; Mol BW
Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
Tsai HD; Chen CM; Lo HY; Chang CC
Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
Peñarrubia J; Balasch J; Fábregues F; Creus M; Casamitjana R; Ballescá JL; Puerto B; Vanrell JA
Hum Reprod; 1998 Dec; 13(12):3315-8. PubMed ID: 9886506
[TBL] [Abstract][Full Text] [Related]
20. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]